Wei Lou

Author PubWeight™ 48.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study. Ann Intern Med 2013 2.23
2 NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants. Mol Cancer Ther 2013 1.81
3 Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res 2003 1.80
4 Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol 2005 1.69
5 Stat3 activation in prostatic carcinomas. Prostate 2002 1.61
6 Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2. Clin Cancer Res 2006 1.58
7 Lin28 promotes growth of prostate cancer cells and activates the androgen receptor. Am J Pathol 2013 1.53
8 MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. J Biol Chem 2011 1.52
9 Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci U S A 2006 1.46
10 Acceptability of HIV/AIDS counseling and testing among premarital couples in China. AIDS Educ Prev 2005 1.34
11 Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res 2009 1.32
12 MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PLoS One 2012 1.30
13 Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. Cancer Res 2010 1.29
14 Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Prostate 2007 1.23
15 NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate 2008 1.21
16 Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol 2002 1.20
17 RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 2004 1.15
18 Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. Prostate 2004 1.14
19 Functional p53 determines docetaxel sensitivity in prostate cancer cells. Prostate 2012 1.10
20 Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther 2013 1.03
21 Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer 2010 1.01
22 Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Prostate 2008 1.00
23 Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. Prostate 2005 0.99
24 Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells. Prostate 2013 0.98
25 Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. Prostate 2002 0.98
26 Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). Prostate 2014 0.98
27 Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 2011 0.97
28 Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer. Genes Cancer 2011 0.96
29 Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells. Exp Cell Res 2011 0.94
30 Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer. Mol Cancer Ther 2006 0.93
31 Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway. Oncogene 2003 0.93
32 T cell subsets in cord blood are influenced by maternal allergy and associated with atopic dermatitis. Pediatr Allergy Immunol 2013 0.93
33 Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis. Clin Immunol 2010 0.89
34 Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res 2005 0.87
35 Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells. Endocr Relat Cancer 2014 0.86
36 RhoGDIα suppresses growth and survival of prostate cancer cells. Prostate 2011 0.86
37 Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer 2010 0.83
38 Interleukin-4 activates androgen receptor through CBP/p300. Prostate 2009 0.81
39 RhoGDIα downregulates androgen receptor signaling in prostate cancer cells. Prostate 2013 0.80
40 Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. Prostate 2003 0.78
41 [Anti-tumor effects on human laryngeal carcinoma Hep-2 of recombinant fowlpox virus expressing chicken anemia virus Apoptin gene]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009 0.77
42 FOXP3-marked IL-17a-producing regulatory T cells are increased in patients with allergic rhinitis. Acta Otolaryngol 2012 0.77
43 Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun 2008 0.76
44 Microbiological safety of household membrane water filter. J Environ Biol 2013 0.75
45 [Tympanoplasty with soft-wall reconstruction of ear canal]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011 0.75
46 [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012 0.75